Shutterstock/Andrey Kuzmyk
Available rooms: Minimum stay of 2 weeks, featuring a private bathroom. Enjoy a complimentary pool. Package includes meals, Wi-Fi, and infectious viruses. Call now!
Would you be inclined to respond to such advertisements? What about those that guarantee severe diarrhea? How many stars would it take to make you consider adding STDs to your stay? Perhaps a substantial cash incentive might sway your decision?
Welcome to the peculiar realm of human challenge testing – arriving soon at a biosecure isolation facility nearby.
In response to the collective trauma of the coronavirus pandemic, researchers are increasingly enlisting healthy individuals to participate in trials that intentionally expose them to illness. Volunteers are now more willing than ever to contract diseases ranging from dysentery and cholera to gonorrhea.
As detailed on page 38, clinical trials offer a rapid and relatively affordable method for assessing vaccines and treatments while monitoring infection dynamics. Contrary to popular belief, the risks may not be as high as presumed. Trials, conducted under stringent medical oversight, will only proceed if effective therapies can quickly alleviate symptoms.
“
Deliberately infecting healthy volunteers carries risks, and the ethical implications are complex.
“
However, it’s not without its hazards, and the ethical landscape remains murky. Unlike patients with existing conditions who may opt for experimental therapies that could potentially cure them, challenge trials seek to induce illness with little or no immediate medical benefit, even if for a brief duration.
Moreover, we cannot always prevent potential long-term consequences. For example, some ethicists have expressed concerns regarding the manner in which British scientists conducted COVID-19 challenge trials during the pandemic, underscoring the risks of chronic symptoms associated with COVID-19.
Nonetheless, the pandemic has also underscored the significant positive impact and value of vaccines. Current data indicates that human challenge testing is safe, particularly for young, healthy individuals. These studies could hasten the development of new defenses against persistent epidemics such as malaria, Zika, and norovirus. The pressing question may be: How can we expand these efforts?
Source: www.newscientist.com
